RNS Number:4889D
Hikma Pharmaceuticals Plc
24 May 2006



                            Section 198 Notification

London, 24 May 2006 - On 23rd May 2006, Hikma Pharmaceuticals PLC (LSE: HIK) 
(DIFX: HIK) ("the Company") received notification from The Capital Group 
Companies, Inc., pursuant to Section 198 Companies Act 1985, that at the close 
of its business on 19th May 2006, The Capital Group Companies, Inc., on behalf 
of its affiliates, including Capital Research and Management Company, had an 
interest in 5,251,350 ordinary shares of 10p each in the Company, which 
represents 3.14 per cent of the issued ordinary share capital of the Company, 
as follows:

                                                                   No. of shares

Capital Research and Management Company                            5,251,350
held as follows:
  State Street Nominees Limited                                    4,097,500
  Chase Nominees Limited                                           1,153,850


                                    - ENDS -


Enquiries:


Hikma Pharmaceuticals PLC                             +44 20 7399 2670
Henry Knowles, Company Secretary
Susan Ringdal, Investor Relations Director

Brunswick Group LLP                                   +44 20 7404 5959
Jon Coles / Wendel Verbeek / Justine McIlroy / Alex
Tweed

Notes to Editors

About Hikma
Hikma Pharmaceuticals PLC is a multinational pharmaceutical group focused on
developing, manufacturing and marketing a broad range of both branded and
non-branded generic and in-licensed pharmaceutical products. Hikma's operations
are conducted through three businesses: Generic, Branded and Injectable
Pharmaceuticals. Hikma's operations are based principally in the United States,
the Middle East and North Africa ("MENA") region and Europe. In 2005, the Group
had revenue of $262 million and profit attributable to shareholders of $44
million. At 31 December 2005, the Group had over 1,800 employees. For news and
other information, please visit www.hikma.com.




                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
HOLILFVIELISFIR
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Hikma Pharmaceuticals Charts.
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Hikma Pharmaceuticals Charts.